Latest Articles
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade
Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE
Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit
Published: Feb. 10, 2026, 9:36 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - thehindu.com
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication thehindu.com
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - The Hindu
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication The Hindu
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi - Business Standard
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi Business Standard
Published: Feb. 10, 2026, 9:10 a.m.
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication - The Economic Times
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication The Economic Times
Published: Feb. 10, 2026, 8:44 a.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz
AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz
Published: Feb. 10, 2026, 8:42 a.m.
Rorisang Thandekiso On How God Came Through for Her When She Was Wheelchair Bound - Youth Village
Rorisang Thandekiso On How God Came Through for Her When She Was Wheelchair Bound Youth Village
Published: Feb. 10, 2026, 8:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma
Published: Feb. 10, 2026, 6:40 a.m.
Link copied to clipboard!